MedTrace Logo

Postoperative Pain Control With Lipossomic Extended Release Bupivacaine

NCT03560362 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-06-20

No results posted yet for this study

Summary

Randomized trial of intraoperative intercostal block with bupivacaine with epinephrine compared to lipossomal extended release bupivacaine.

Conditions

Interventions

DRUG

Bupivacaine liposome

DRUG

Bupivacaine / Epinephrine

Sponsors & Collaborators

  • University of Tennessee

    lead OTHER

Principal Investigators

  • Benny Weksler, MD · University of Tennessee

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-09
Primary Completion
2018-10-31
Completion
2018-10-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03560362 on ClinicalTrials.gov